Kunming Longjin Pharmaceutical Co Ltd Strategic Asset Allocation Index
Kunming Longjin Pharmaceutical Co Ltd strategic asset allocation index. Kunming Longjin Pharmaceutical Co Ltd (002750) has a Strategic Asset Allocation Index of 31.6% as of September 2023. Strategic assets (PP&E of CN¥184.25 Million plus long-term investments of CN¥-) total CN¥184.25 Million, measured against net assets of CN¥582.16 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Kunming Longjin Pharmaceutical Co Ltd balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Kunming Longjin Pharmaceutical Co Ltd (2011–2022)
Strategic asset allocation index of Kunming Longjin Pharmaceutical Co Ltd from 2011 to 2022. This chart shows how Kunming Longjin Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of September 2023, the index stands at 31.6%, representing strategic assets of CN¥184.25 Million against net assets of CN¥582.16 Million CNY. Check 002750 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Kunming Longjin Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2011–2022)
Kunming Longjin Pharmaceutical Co Ltd strategic asset allocation index by year from 2011 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Kunming Longjin Pharmaceutical Co Ltd from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 002750 company net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 33.5% | CN¥202.48 Million | CN¥202.48 Million | CN¥- | CN¥604.77 Million | ▲ +0.6 pp |
| 2021 | 32.9% | CN¥223.25 Million | CN¥223.25 Million | CN¥- | CN¥678.29 Million | ▼ -1.1 pp |
| 2020 | 34.0% | CN¥239.53 Million | CN¥239.53 Million | CN¥- | CN¥704.71 Million | ▼ -2.4 pp |
| 2019 | 36.4% | CN¥242.36 Million | CN¥242.36 Million | CN¥- | CN¥665.89 Million | ▼ -2.4 pp |
| 2018 | 38.8% | CN¥254.22 Million | CN¥230.52 Million | CN¥23.70 Million | CN¥655.93 Million | ▼ -3.5 pp |
| 2017 | 42.3% | CN¥272.95 Million | CN¥245.65 Million | CN¥27.30 Million | CN¥645.54 Million | ▲ +0.7 pp |
| 2016 | 41.6% | CN¥279.01 Million | CN¥247.66 Million | CN¥31.35 Million | CN¥670.46 Million | ▼ -2.0 pp |
| 2015 | 43.6% | CN¥261.61 Million | CN¥261.61 Million | CN¥- | CN¥599.41 Million | ▼ -54.1 pp |
| 2014 | 97.7% | CN¥279.08 Million | CN¥279.08 Million | CN¥- | CN¥285.57 Million | ▼ -1.3 pp |
| 2013 | 99.1% | CN¥299.18 Million | CN¥299.18 Million | CN¥- | CN¥302.00 Million | ▲ +3.1 pp |
| 2012 | 95.9% | CN¥217.69 Million | CN¥217.69 Million | CN¥- | CN¥226.94 Million | ▲ +21.0 pp |
| 2011 | 74.9% | CN¥139.83 Million | CN¥139.83 Million | CN¥- | CN¥186.74 Million | — |